Tri Locum Partners LP

Tri Locum Partners LP reported 18 holdings worth US$506M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Tri Locum Partners LP reported 18 holdings worth US$506M as of Sep 30, 2026. Largest: Vertex Pharmaceuticals Incorporated, Eli Lilly and Company and Teva Pharmaceutical Industries Limited. Filed Nov 16, 2026 (Form 13F).

Holdings
18
Value as reported
US$506M

The filing in full

CompanySharesValue as reported% of portfolio
Vertex Pharmaceuticals Incorporated133KUS$69.5M13.7%
Eli Lilly and Company51,015US$59M11.7%
Teva Pharmaceutical Industries Limited1.22MUS$48.5M9.6%
Amneal Pharmaceuticals, Inc.2.33MUS$46.9M9.3%
DexCom, Inc.489KUS$42.2M8.3%
argenx SE30,399US$29.1M5.8%
Axsome Therapeutics, Inc.143KUS$26.4M5.2%
Johnson & Johnson73,559US$19.5M3.8%
Enliven Therapeutics, Inc.410KUS$18.8M3.7%
United Therapeutics Corporation33,000US$17.9M3.5%
Madrigal Pharmaceuticals, Inc.33,668US$17M3.4%
Celcuity Inc.203KUS$16.1M3.2%
Dianthus Therapeutics, Inc.177KUS$15.6M3.1%
Revolution Medicines, Inc.40,019US$8.21M1.6%
Definium Therapeutics, Inc.144KUS$5.5M1.1%
Viridian Therapeutics, Inc.90,107US$1.86M0.37%
Beta Bionics, Inc.0US$00.00%
Cytokinetics, Incorporated0US$00.00%
Intuitive Surgical, Inc.0US$00.00%
Tarsus Pharmaceuticals, Inc.0US$00.00%

Source

Download original · View original at SEC

Related